News Check all IrsiCaixa scientific news in just one click. Breadcrumb Home News SARS-CoV-2 09/05/2022 Some antigen tests are 10 times less sensitive against certain SARS-CoV-2 variants, but effective with omicron Living Lab for Health 30/03/2022 Improving the mental health promotion model in schools: a priority challenge for the education community HIV Viral reservoir 27/03/2022 People with low HIV reservoir and located in short-lived cells, an ideal scenario for eradicating the virus SARS-CoV-2 22/02/2022 Light-based device uses a few drops of saliva to effectively test COVID-19 patients SARS-CoV-2 Therapies 16/02/2022 Key to plitidepsin's success, preventing SARS-CoV-2 replication inside cells SARS-CoV-2 Vaccines 19/01/2022 The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients SARS-CoV-2 Therapies 22/12/2021 Study shows efficacy of remdesivir in preventing severity of COVID-19 and European Commission extends its use in people at risk 20/12/2021 IrsiCaixa and Vall d’Hebron map the HIV reservoir and describe the atlas of cells where the virus is hidden 30/11/2021 Use of PrEP in Catalonia could save 93 million euros over the next 40 years Pagination First Previous … Page 4 Page 5 Page 6 Page 7 8 Page 9 Page 10 Page 11 Page 12 … Next Last
SARS-CoV-2 09/05/2022 Some antigen tests are 10 times less sensitive against certain SARS-CoV-2 variants, but effective with omicron
Living Lab for Health 30/03/2022 Improving the mental health promotion model in schools: a priority challenge for the education community
HIV Viral reservoir 27/03/2022 People with low HIV reservoir and located in short-lived cells, an ideal scenario for eradicating the virus
SARS-CoV-2 22/02/2022 Light-based device uses a few drops of saliva to effectively test COVID-19 patients
SARS-CoV-2 Therapies 16/02/2022 Key to plitidepsin's success, preventing SARS-CoV-2 replication inside cells
SARS-CoV-2 Vaccines 19/01/2022 The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients
SARS-CoV-2 Therapies 22/12/2021 Study shows efficacy of remdesivir in preventing severity of COVID-19 and European Commission extends its use in people at risk
20/12/2021 IrsiCaixa and Vall d’Hebron map the HIV reservoir and describe the atlas of cells where the virus is hidden